FXI News 34.70 05/06/2014 04:58:52 FTSE China 25 Index Fund Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
FTSE China 25 Index Fund Ishares (FXI) 34.70 $FXI

Deutsche Bank Launches All China ETF - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri May 02, 2:00PM CDT
Deutsche Bank introduced db X-trackers Harvest MSCI All China Equity Fund (CN) on the last trading day of April.

iShares FTSE Rises 1.33% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 29, 3:41PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $35.06 to a high of $35.38. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $35.14 on volume of 20.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares FTSE Set to Possibly Pullback After Yesterday's Rally of 1.33%
Comtex SmarTrend(R) - Tue Apr 29, 3:41PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $35.06 to a high of $35.38. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $35.14 on volume of 20.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares FTSE China 25 Index Fund (FXI) : Stop activated ($34.30)
Trading Central - Fri Apr 25, 8:49AM CDT
The ETF has reached our stop loss which was set at $34.30. Performance: -6.41%.

SmarTrend Watching for Potential Rebound in Shares of iShares FTSE After 1.36% Loss
Comtex SmarTrend(R) - Wed Apr 23, 3:46PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $34.71 to a high of $34.98. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $35.39 on volume of 19.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iShares FTSE to Potentially Rebound After Falling 2.51% Yesterday
Comtex SmarTrend(R) - Tue Apr 15, 3:44PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $34.98 to a high of $35.55. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $35.97 on volume of 45.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 2.51%, iShares FTSE Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 15, 3:43PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $34.98 to a high of $35.55. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $35.97 on volume of 45.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Jim Cramer Says The Ukraine-Russia Conflict Is Causing U.S. Problems
at The Street - Mon Apr 14, 1:47PM CDT
Speculation abounds that interest rates could drop despite extremely strong U.S. data, and Jim Cramer brings up his three "black holes" in that regard: the Ukraine/Russia conflict, Japan and China. Cramer calls Japan "a disaster" after the nation...

Is China Slowing Down? - Ahead of Wall Street
Sheraz Mian - ZACKS - Thu Apr 10, 8:32AM CDT
Chinese trade data may not be reliable, but there is plenty of other evidence indicating that the country's economy is slowing down.

SmarTrend Watching for Potential Pullback in Shares of iShares FTSE After 1.65% Gain
Comtex SmarTrend(R) - Tue Apr 08, 3:42PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $36.31 to a high of $36.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $36.38 on volume of 34.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.65% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 08, 3:42PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $36.31 to a high of $36.80. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $36.38 on volume of 34.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares FTSE China 25 Index Fund (FXI) : Buy @ $36.65
Trading Central - Tue Apr 08, 10:34AM CDT
From a technical view, the ETF has broken above a key declining trend line which has been in place since December 2013. Regarding technical indicators, the daily MACD has validated a bullish divergence while the daily RSI is pushing above a bearish...

The New China Stimulus: Sound Policy or Desperation? - Real Time Insight
Tracey Ryniec - Zacks Investment Research - Thu Apr 03, 1:06PM CDT
With its economy sputtering, China finally announced stimulus measures.

Is Chinese Stimulus a Sign of Weakness? - Ahead of Wall Street
Sheraz Mian - ZACKS - Thu Apr 03, 8:49AM CDT
Markets will cheer the package, but the plan spotlights the weakness, vulnerability and the economy's over-reliance on state support.

iShares FTSE Set to Possibly Pullback After Yesterday's Rally of 2.11%
Comtex SmarTrend(R) - Fri Mar 28, 3:41PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $35.67 to a high of $36.10. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $36.08 on volume of 52.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Updated Category News Views 64

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Continue Reading
Cloopen Group's Private Transition: What Investors Should Know

Updated Category News Views 121

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 0

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Freddy’s Joins Hershey For a Limited-Time Flavor Fest

Updated Category News Views 95

The Sweet Collaboration We Didn't See Coming Well, folks, here's a tasty twist for you—Freddy's Frozen Custard & Steakburgers is cozying up to The Hershey Company to bring a sugar rush to our mundane lives. Starting Nov. 4, they're rolling out a limited-time series of treats so indulgent you'll want to skip straight to dessert. And if that wasn't enough, they're...

Continue Reading
Bloomberg Law Integrates Docket Data with AI Platform

Updated Category News Views 0

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 67

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
Genedata's New ELN Transforms Biopharma R&D Workflows

Updated Category News Views 58

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

Continue Reading
J.H. Strain & Sons' Asset Sale Seals a New Era

Updated Category News Views 59

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 0

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading

Top 5 Most Recently Viewed Articles

Lilly Flexes Oncology Muscle at 2026 ASCO Meet

Updated Category News Views 19

Lilly's Pipeline Gets the Spotlight With the ASCO conference kicking off in Chicago this year, Eli Lilly (NYSE: LLY) is coming in guns blazing. The company's oncology roster is vast and spread across a variety of tumor types and treatment modalities. This year's presentations are dripping with promise. You got Retevmo leading the charge in a plenary session, joined by...

Continue Reading
David Brenneman Strengthens Antitrust Practice at Latham

Updated Category News Views 212

David Brenneman Joins Latham & Watkins Latham & Watkins LLP is excited to announce a significant addition to their Antitrust & Competition Practice. Renowned antitrust lawyer David Brenneman has joined their Washington, D.C. office as a partner. Brenneman brings considerable expertise in managing the antitrust aspects of various mergers and acquisitions, enhancing the...

Continue Reading
Join the Class Action for Viatris Inc.: Important Updates

Updated Category News Views 419

Understanding the Viatris Class Action Opportunity Attention, investors! If you've purchased securities of Viatris Inc. (NASDAQ: VTRS), this is a critical time for you. The Rosen Law Firm, renowned for advocating investor rights globally, is reaching out to individuals who bought Viatris stocks during an identified time frame. Having knowledge of these events is essential...

Continue Reading
Transformative Health Education: Empowering Future Generations

Updated Category News Views 120

Understanding the Growing Health Crisis A crisis is quietly unfolding in classrooms across the nation: rising rates of preventable chronic illnesses, mental health struggles, and pervasive health illiteracy are significantly impacting the wellness of today's youth. In the face of these alarming statistics, Know Yourself Academy emerges as a beacon of hope, aiming to...

Continue Reading
Free Guide by Pacific Mind Health Eases Anxiety

Updated Category News Views 11

Wrestling with Your Inner Spotlight? Pacific Mind Health Steps In There's a good chance most of us have been there—sweatin' the small stuff like we're the star attraction in the circus of life, convinced everyone else is watching as we trip over our own shoelaces. Well, don't sweat it. Pacific Mind Health has jumped in to lend a hand with some real tools to shake off...

Continue Reading